Follow the Orchard Therapeutics plc stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Orchard Therapeutics plc has published 10 public disclosures. Market capitalisation: €359.6m. The latest transaction was disclosed on 24 January 2024 (Disposition). Among the most active insiders: THOMAS FRANK E. All data is openly available.
10
Insider Decl.
n/a
Thresholds
€16,762
2 ops.
Buy Volume
n/a
6 ops.
Sell Volume
54Σ signal
Buys €16,762n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,222 of 29,064 companies
48.8
score / 100
Value
52
Quality
45
FCF yld12%
Earn yld-36%
EV/EBITDA9.2x
ROE15%
Gross mgn·
Net mgn·
Debt/EBITDA6.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.